Ross Muken
Stock Analyst at Evercore ISI Group
(1.49)
# 3,155
Out of 5,182 analysts
49
Total ratings
53.57%
Success rate
-1.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $200 | $166.79 | +19.91% | 11 | Feb 19, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $76.12 | -8.04% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $102.49 | +134.17% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $114.87 | +13.17% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $34.02 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $205.61 | -67.41% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $126.92 | +96.97% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $470.22 | -53.21% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $9.05 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Feb 19, 2026
Maintains: Outperform
Price Target: $260 → $200
Current: $166.79
Upside: +19.91%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $76.12
Upside: -8.04%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $102.49
Upside: +134.17%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $114.87
Upside: +13.17%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $34.02
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $205.61
Upside: -67.41%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $126.92
Upside: +96.97%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $470.22
Upside: -53.21%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $9.05
Upside: -